Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer

Clinical trial NCT05173103 · COMPLETED

Trial details

NCT number: NCT05173103
Sponsor: University of Milano Bicocca
Status: COMPLETED
Study type: OBSERVATIONAL

Advanced Breast Cancer Hormone Receptor Positive Breast Carcinoma HER2-negative Breast Cancer

Start date: 2021-09-24
Primary completion: 2024-01-30
Enrollment: 254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.